Skip to main content
. 2016 Jun 29;80(3):679–731. doi: 10.1128/MMBR.00065-15

TABLE 1.

Summary of HIV pairwise protein interactionsa

Protein 1-protein 2 Life stage(s) Major function(s) Positions in protein 1 (reference[s]) Positions in protein 2 (reference[s]) Reference(s)
GP120-GP41 Entry, budding Promotes viral entry, promotes viral budding, promotes Env packaging 31–46, 50–54, 70–75, 84–89, 91, 103, 106, 107, 110, 111, 114, 215, 220–224, 226, 244, 246, 489–505 (50) 520–528, 530, 533, 534, 536, 537, 540, 541, 543–546, 569–572, 574, 575, 577–579, 581, 582, 585, 586, 588–592, 593, 596–598, 601–610, 614, 617–619, 622, 623, 628, 629, 631–633, 635, 636, 639, 642, 643, 646, 650, 651, 654, 658, 659, 661–663 (50) 4858
GP41Env-matrix Entry, budding Promotes viral entry, promotes Env packaging 712, 713–856 (70, 84); 764–856 (591); 814–844 (73) 12, 30, 34 (76); 18, 20, 22, 32, 33 (83, 592); 6, 29, 31, 62 (74); 49 (84); 62 (72); 84, 99 (75) 6976, 83, 84, 591, 592
GP120-Tat Entry Promotes viral entry 166–171 (89); 157–171 (86) 73–86 (86) 86, 89
RT-integrase Reverse transcription, integration Enhances RT activity, inhibits integrase activity 1–242, 387–421 (108) 201–288 (108); 243, 250, 258, 220–270 (102); 213–288 (106) 102, 106, 108
RT-nucleocapsid Reverse transcription Enhances RT activity 548–560, p51 domain (113) 13–30, 34–51 (110, 111) 110, 111, 113
RT-Vif Reverse transcription Enhances RT activity ? 161–164 131
RT-Tat Reverse transcription Enhances RT activity ? 49–57 139
RT-Nef Reverse transcription Enhances RT activity p51 domain 154–172 148
Protease-Tat Reverse transcription Protease cleaves Tat to enhance reverse transcription Protease catalytic site 49–57 152
Integrase-Rev Integration Inhibits integrase activity 66–80, 118–128 (173) 12–23, 53–67 (173) 173175, 180
Integrase-matrix Integration Enhances nuclear import of the PIC 50–212 132 181
Matrix-Vpr Integration Enhances nuclear import of the PIC 88–132 ? 183
Integrase-Nef Integration ? ? 58–206 149
Tat-Vpr Transcription Enhances viral transcription 50–67 ? 220
Tat-Rev Transcription Proteasomal degradation of Tat ? 35–50 216
Tat-Nef Transcription Enhanced viral transcription ? ? 223
Tat-nucleocapsid Transcription NC induces Tat degradation ? ? 228
Vif-Vpr Transcription Vif mediates Vpr degradation ? ? 232
NCGag-Vif Budding Vif packaging, viral core stability, inhibits PR cleavage 44–55 (301) 75–114 (300) 300, 301, 303
NCGag-Vpr Budding Vpr packaging 13–30, 34–51 70–80 313
p6Gag-Vpr Budding Vpr packaging 15–18 (329); 32–46 (325); 34–36 (326); 35–47 (330); 41–46 (322) 18–34 (322); 1–71 (327) 322, 325327, 329, 330
p6Gag-Vpx Budding Vpx packaging 15–40 (333) 73–89 (333) 314, 332, 333
GP41Env-Nef Budding Env packaging 712–715 181–210 336
Gag-RT Budding RT packaging 183–305 (347) ? 347, 348
Protease-Gag/GagPol Maturation Gag and GagPol cleavage Protease catalytic site Gag/GagPol cleavage sites 495497
Protease-Vif Maturation Inhibits protease activity 1–9 (516, 517) 30–65 (519); 41–65 (520); 78–98 (516); 81–88, 88–98 (521) 516, 517, 519521
Protease-RT Maturation Protease cleaves RTGagPol, RT promotes protease activity, protease inhibits RT activity Protease catalytic site 440 | 441 522, 593
Protease-Nef Maturation Protease cleaves Nef, Nef inhibits protease activity Protease catalytic site 57 | 58 528
Protease-GP41CT Maturation Protease cleaves GP41CT Protease catalytic site 714 | 715, 716 | 717 538
a

A question mark indicates that the corresponding information is not available. A vertical line indicates a protease cleavage site (e.g., 57 | 58 suggests that HIV protease cleaves the substrate protein between amino acid positions 57 and 58). Position indices of GP120 and GP41 are based on the Env protein sequence in the HIV-1 HXB2 reference strain. Except for HIV-2 Vpx, interaction domains are reported for HIV-1.